Alberto Zambelli

31PUBLICATIONS
198CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Data mining and knowledge discovery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jul 17, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Jan 09, 2026
Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch Next.

Fausto Petrelli, Alessandro Iaculli, Alberto Zambelli

|Nov 06, 2025
Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast Cancer.

Elena Zazzetti, Saverio D'Amico, Flavia Jacobs

|Aug 20, 2025
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Andrea Botticelli, Chiara Cremolini, Simone Scagnoli

Pageof 6

Frequent Collaborators

16 joint publications

Rita De Sanctis

11 joint publications

Flavia Jacobs

9 joint publications

Armando Santoro

8 joint publications

Paola Tiberio